Member Info for Prion25

Https://www.sciencedirect.com/science/article/pii/S0378775325021172

The structural shift from the licensing model to a hybrid model where Ceres will supply their complex IP protected fuel cells produces a wonderful synergy AI manufacturing for AI data centres power

Https://share.google/5ciY3V7AkdhscOqWZ

Let hope you get a 80th birthday day good news from our team Avacta soon

Don’t forget the Grizzly Short Seller report I panicked and sold half my holdings so many shenanigans and manipulations. Investment banks ignore them always do you own research

What are “the conventional power technologies” nuclear , cold fusion , gas /hydrogen turbines Starlink ? Is it not true in the context of energy and bottlenecks in AI data centres and lack of grid capacity SOFC provides a global solution to a rapidly evolving AI revolution Panmure manipulation?

The charity guy sounds like a charlatan .Need not go to Conferences he is in contact with desperate sufferers who can give their experiences you would have thought . As it’s a great unmet need and regarded as untreatable he could at least sounded hopeful

Give it a break SGC a great unmet need and a very rare cancer as little as 500 case per annum in UK and those case will have to meet the stringent trial criteria Avacta have done well in obtaining suitable patients for the trial Given the enduring PFS the number of deaths will decline each year which is great news for sufferers The lack of mitigation by some on this BB is unrelenting

The median PFS has frequently not been reached during trials, showing a massive extension compared to the standard 3.5-month Dox

Https://uk.finance.yahoo.com/news/ubs-nearly-doubles-ceres-power-103000253.html

The best is yet to come

https://www.asco.org/annual-meeting/abstracts-presentations/submission-details/late-breaking-data-submission-guidelines

AGM scheduled for 10 am this morning

No RNS red dot on LSE

Https://www.londonstockexchange.com/news-article/TCF/positive-ox-1-tox-data-in-addiction-programme/17591160

Must be dreaming about Hantavrius mRNA vaccine trials

The precision platform chemistry is novel and has been so far be shown to work above expectations The drugs are already ready out there in the market imo

Average time to produce and bring a novel cancer drug to market 10 -15 years Avacta better than average ?

In my opinion the jabs are only a substitute for infusion to mop up any cancer cells after surgery The efficacy and safety of the jab is very much the same as infusion but patients will benefit by less time sat around in hospital receiving the immunotherapy by infusion which may take hours to be replaced by a jab which takes minutes All treatments for cancer are good news potentially Avacta treated patients could receive the jab as as a combination therapy which is the direction oncology is moving

That written evidence is frustrating and depressing Genedrive have done all they can with innovative diagnostics to improve outcomes save money for the NHS but there is no pathway for deployment of diagnostics into NHS England because of misaligned funding etc Surely this should be brought to attention of Wes Streeting no pun intended but this problem should be right up his street banging on about preventative medicine, technology and saving money

Just seen the presentation update very impressive.But I felt somewhat left behind and panic stricken like when I a was a school boy returning from sickness and everyone in the class doing something called quadratic equations Need to catch up things have advanced to exciting level

Https://www.hl.co.uk/feeds/apps/sharecast?id=35868622

No problem copying H&L link